World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 43 2957 2688 75 72 76 10248

Clare Stirzaker publications per year

The chart shows the history of publications by Clare Stirzaker between 1997 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Clare Stirzaker published across 29 years, from 1997 to 2025, averaging 4.5 papers a year. Output peaked at 46 publications in 2023. 8 of the 131 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1997 to 2025. Vertical axis: number of publications, 0 to 46. Peak 46 publications in 2023. 1997: 2 publications 1998: 1 publication 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 2 publications 2003: 0 publications 2004: 1 publication 2005: 0 publications 2006: 2 publications 2007: 2 publications 2008: 0 publications 2009: 1 publication 2010: 3 publications 2011: 4 publications 2012: 4 publications 2013: 3 publications 2014: 2 publications 2015: 7 publications 2016: 6 publications 2017: 5 publications 2018: 8 publications 2019: 8 publications 2020: 7 publications 2021: 6 publications 2022: 3 publications 2023: 46 publications 2024: 6 publications 2025: 2 publications
1997 2025

131 publications in total across all disciplines

View publications per year as a table
Clare Stirzaker: publications per year, 1997 to 2025
Year Publications
1997 2
1998 1
1999 0
2000 0
2001 0
2002 2
2003 0
2004 1
2005 0
2006 2
2007 2
2008 0
2009 1
2010 3
2011 4
2012 4
2013 3
2014 2
2015 7
2016 6
2017 5
2018 8
2019 8
2020 7
2021 6
2022 3
2023 46
2024 6
2025 2
Total 131
Download as CSV

Clare Stirzaker publications per year - data summary

  • Clare Stirzaker, a Molecular Biology scholar from Garvan Institute of Medical Research, has 131 publications recorded across 29 years, from 1997 to 2025.
  • The oldest publication on record dates to 1997 and the most recent to 2025.
  • The most productive year is 2023, with 46 publications.
  • The least productive years with any output are 1998, 2004 and 2009, with 1 publication each.
  • 6 of the 29 years in the span carry no publications at all (1999, 2000, 2001, 2003 and others).
  • The rate of publication averages 4.5 papers per year over the whole span, or 5.7 per year counting only the 23 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 63 publications, 48% of the career total.
  • Split into equal eras - 1997-2006: 8 publications (0.8 per year); 2007-2016: 32 publications (3.2 per year); 2017-2025: 91 publications (10.1 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Clare Stirzaker publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Clare Stirzaker sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 67–76 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 76 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65 76
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Clare Stirzaker publication distribution in Molecular Biology in 2026 - data summary

  • The chart plots the publication count of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 53 ranges running from 47–56 to 564+ publications.
  • Clare Stirzaker, a Molecular Biology scholar from Garvan Institute of Medical Research, records 76 publications - the 3rd percentile of the discipline.
  • 3% of ranked Molecular Biology scientists score the same or lower than Clare Stirzaker, and about 97% score higher.
  • The median of the discipline falls in the 177–186 publications range, and Clare Stirzaker ranks below the median.
  • The most crowded range is 117–126 publications, holding 177 scientists (6% of the field).
  • 53% of the field sits in the lowest quarter of the value range (up to 177–186 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 564 publications or more, 100 scientists in all (3% of the field).

Clare Stirzaker D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Clare Stirzaker sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 42–43 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 43 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101 43
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Clare Stirzaker D-index placement in Molecular Biology in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 54 ranges running from 40–41 to 145+ D-Index.
  • Clare Stirzaker, a Molecular Biology scholar from Garvan Institute of Medical Research, records 43 D-Index - the 4th percentile of the discipline.
  • 4% of ranked Molecular Biology scientists score the same or lower than Clare Stirzaker, and about 96% score higher.
  • The median of the discipline falls in the 68–69 D-Index range, and Clare Stirzaker ranks below the median.
  • The most crowded range is 64–65 D-Index, holding 131 scientists (4% of the field).
  • 50% of the field sits in the lowest quarter of the value range (up to 66–67 D-Index), so the distribution leans towards the lower end of the scale.
  • The final bar has no upper bound: it groups every scientist with 145 D-Index or more, 100 scientists in all (3% of the field).

Overview

Clare Stirzaker is affiliated with the Garvan Institute of Medical Research in Australia. Their research spans several key areas within biochemistry, genetics, molecular biology, and medicine, with a significant focus on molecular biology and cancer research.

Their work extensively covers topics related to epigenetics and DNA methylation, genomics and chromatin dynamics, RNA modifications and cancer, cancer genomics and diagnostics, cancer-related gene regulation, prostate cancer treatment and research, and histone deacetylase inhibitors research.

Stirzaker's publication record includes a number of articles in various reputable scientific journals. Selected recent papers include:

  • "Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer," 2020, Nature Communications
  • "Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains," 2020, Nature Communications
  • "DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity," 2021, Cell Reports
  • "Epigenetic Therapies and Biomarkers in Breast Cancer," 2022, Cancers
  • "Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling," 2024, BMC Genomics

They frequently collaborate with other researchers, including Susan J. Clark, Ruth Pidsley, Joanna Achinger-Kawecka, Phuc-Loi Luu, and Qian Du, reflecting multidisciplinary engagement in their research projects.

Stirzaker has published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Clinical Epigenetics, Pathology, Nature Communications, and Cancers. The largest number of their publications appear in bioRxiv, indicating involvement in ongoing and preliminary research dissemination as well as peer-reviewed journals.

Their fields of study are primarily rooted in biochemistry, genetics, and molecular biology with particular attention to the molecular mechanisms underlying cancer and related diseases. Within these broad areas, they focus on advanced topics such as chromatin dynamics, DNA methylation patterns, and the impact of epigenetic regulation on cancer progression and treatment strategies.

Best Publications

  • Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling

    Ruth Pidsley;Ruth Pidsley;Elena Zotenko;Elena Zotenko;Timothy J. Peters;Mitchell G. Lawrence

  • Methyl-CpG-binding domain proteins: readers of the epigenome.

    Qian Du;Phuc-Loi Luu;Clare Stirzaker;Clare Stirzaker;Susan J Clark;Susan J Clark

  • Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA

    Peter M. Warnecke;Clare Stirzaker;John R. Melki;Douglas S. Millar

  • Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band

    Jordi Frigola;Jenny Song;Clare Stirzaker;Rebecca A Hinshelwood

  • DNA methylation: bisulphite modification and analysis.

    Susan J Clark;Aaron Statham;Clare Stirzaker;Peter L Molloy

  • Extensive DNA Methylation Spanning the Rb Promoter in Retinoblastoma Tumors

    Clare Stirzaker;Douglas S. Millar;Cheryl L. Paul;Peter M. Warnecke

  • Identification and resolution of artifacts in bisulfite sequencing

    Peter M Warnecke;Clare Stirzaker;Jenny Song;Christoph Grunau

  • Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations

    Phillippa C. Taberlay;Joanna Achinger-Kawecka;Aaron T.L. Lun;Fabian A. Buske

  • Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

    Christoph Bock;Florian Halbritter;Francisco J. Carmona;Sascha Tierling

  • Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells

    Clare Stirzaker;Jenny Z. Song;Ben Davidson;Susan J. Clark

  • Regional activation of the cancer genome by long-range epigenetic remodeling.

    Saul A. Bert;Mark D. Robinson;Mark D. Robinson;Mark D. Robinson;Dario Strbenac;Aaron L. Statham

  • Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias

    Shalima S. Nair;Marcel W. Coolen;Clare Stirzaker;Jenny Z. Song

  • Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer

    Fátima Valdés-Mora;Jenny Z. Song;Aaron L. Statham;Dario Strbenac

  • The DNA methylation landscape in cancer.

    Ksenia Skvortsova;Ksenia Skvortsova;Clare Stirzaker;Clare Stirzaker;Phillippa Taberlay

  • Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity

    Marcel W. Coolen;Clare Stirzaker;Jenny Z. Song;Aaron L. Statham

  • Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.

    Jenny Z Song;Clare Stirzaker;Janet Harrison;John R Melki

  • Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA

    Aaron L. Statham;Mark D. Robinson;Jenny Z. Song;Marcel W. Coolen

  • Mining cancer methylomes: prospects and challenges

    Clare Stirzaker;Phillippa C. Taberlay;Phillippa C. Taberlay;Aaron L. Statham;Susan J. Clark;Susan J. Clark

  • Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.

    Clare Stirzaker;Elena Zotenko;Jenny Z. Song;Wenjia Qu

  • Repitools: an R package for the analysis of enrichment-based epigenomic data.

    Aaron L. Statham;Dario Strbenac;Marcel W. Coolen;Clare Stirzaker

Frequent Co-Authors

Susan J. Clark
Susan J. Clark Garvan Institute of Medical Research
Mark D. Robinson
Mark D. Robinson University of Zurich
Nicola J. Armstrong
Nicola J. Armstrong Murdoch University
James G. Kench
James G. Kench Royal Prince Alfred Hospital
Terence P. Speed
Terence P. Speed Walter and Eliza Hall Institute of Medical Research
Timothy J. Peters
Timothy J. Peters University of Bristol
Roger R. Reddel
Roger R. Reddel Children's Medical Research Institute
Matt Trau
Matt Trau University of Queensland
Joseph E. Powell
Joseph E. Powell Garvan Institute of Medical Research
Michael Buckley
Michael Buckley University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens doors to many evolving healthcare careers. Many students and professionals may be interested in advancing their qualifications online. If you’re coming from a nursing background, several transition programs can help you make that leap, such as adn to np programs, which are designed for associate degree nurses aiming for advanced practice roles.

For those without prior nursing experience, options like direct entry msn online programs help bridge the gap, making it possible to enter advanced nursing professions from related fields such as biology or other sciences.

Choosing the right university is key to your career growth. If you’re considering a bachelor’s to master’s progression, compare your choices with guides such as capella university vs wgu rn to bsn to evaluate program flexibility, cost, and support.

Affordability is another important consideration. Those with a BSN might be interested in finding the cheapest bsn to msn online programs to minimize education expenses while maximizing career advancement.

Best Scientists Citing Clare Stirzaker

Trending Scientists

Recently Published Articles